2026-2031 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region
This report presents a detailed and holistic analysis of the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market. It integrates quantitative data with qualitative insights to equip readers with the necessary information for strategic planning, competitive assessment, market positioning, and data-driven decision-making.
All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.
Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.
Ultimately, this report serves as a vital resource for Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.
By Market Players:
Bausch Health
Allergan
Sebela Pharmaceuticals
Astellas Pharmaceuticals
Amneal Pharms
Pharscin Pharma
By Type
XIFAXAN
Viberzi
Lotronex
Other
By Application
Hospitals Pharmacy
Retail Pharmacy
Other
By Regions/Countries:
North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America
Points Covered in The Report
All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.
Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.
Ultimately, this report serves as a vital resource for Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.
By Market Players:
Bausch Health
Allergan
Sebela Pharmaceuticals
Astellas Pharmaceuticals
Amneal Pharms
Pharscin Pharma
By Type
XIFAXAN
Viberzi
Lotronex
Other
By Application
Hospitals Pharmacy
Retail Pharmacy
Other
By Regions/Countries:
North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America
Points Covered in The Report
- The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
- The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
- The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
- Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
- The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
- To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
- Assess the production processes, major issues, and solutions to mitigate the development risk.
- To understand the most affecting driving and restraining forces in the market and its impact in the global market.
- Learn about the market strategies that are being adopted by leading respective organizations.
- To understand the future outlook and prospects for the market.
- Besides the standard structure reports, we also provide custom research according to specific requirements.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Growth Rate by Type: 2026-2031
1.4.2 XIFAXAN
1.4.3 Viberzi
1.4.4 Lotronex
1.4.5 Other
1.5 Market by Application
1.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application: 2026-2031
1.5.2 Hospitals Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Other
1.6 Study Objectives
1.7 Overview of Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market
1.7.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Status and Outlook (2020-2031)
1.7.2 North America
1.7.3 East Asia
1.7.4 Europe
1.7.5 South Asia
1.7.6 Southeast Asia
1.7.7 Middle East
1.7.8 Africa
1.7.9 Oceania
1.7.10 South America
1.7.11 Rest of the World
2 MANUFACTURING COST STRUCTURE ANALYSIS
2.1 Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
2.2 Industry Chain Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity Market Share by Manufacturers (2020-2025)
3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Manufacturers (2020-2025)
3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Manufacturers (2020-2025)
4 IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS REGIONAL MARKET ANALYSIS
4.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Regions
4.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Regions (2020-2025)
4.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Regions
4.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Regions
4.3 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
4.3.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
4.3.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
4.3.3 Key Manufacturers in North America
4.3.4 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import and Export
4.4 East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
4.4.1 East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
4.4.2 East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
4.4.3 Key Manufacturers in East Asia
4.4.4 East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import & Export
4.5 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
4.5.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
4.5.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
4.5.3 Key Manufacturers in Europe
4.5.4 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import & Export
4.6 South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
4.6.1 South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
4.6.2 South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
4.6.3 Key Manufacturers in South Asia
4.6.4 South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import & Export
4.7 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
4.7.1 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
4.7.2 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
4.7.3 Key Manufacturers in Southeast Asia
4.7.4 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import & Export
4.8 Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
4.8.1 Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
4.8.2 Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
4.8.3 Key Manufacturers in Middle East
4.8.4 Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import & Export
4.9 Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
4.9.1 Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
4.9.2 Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
4.9.3 Key Manufacturers in Africa
4.9.4 Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import & Export
4.10 Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
4.10.1 Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
4.10.2 Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
4.10.3 Key Manufacturers in Oceania
4.10.4 Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import & Export
4.11 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
4.11.1 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
4.11.2 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
4.11.3 Key Manufacturers in South America
4.11.4 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import & Export
5 IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS SALES MARKET BY TYPE (2020-2031)
5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Historic Market Size by Type (2020-2025)
5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecasted Market Size by Type (2026-2031)
6 IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS CONSUMPTION MARKET BY APPLICATION(2020-2031)
6.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Historic Market Size by Application (2020-2025)
6.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecasted Market Size by Application (2026-2031)
7 COMPANY PROFILES AND KEY FIGURES IN IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS BUSINESS
7.1 Bausch Health
7.1.1 Bausch Health Company Profile
7.1.2 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
7.1.3 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.2 Allergan
7.2.1 Allergan Company Profile
7.2.2 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
7.2.3 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.3 Sebela Pharmaceuticals
7.3.1 Sebela Pharmaceuticals Company Profile
7.3.2 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
7.3.3 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.4 Astellas Pharmaceuticals
7.4.1 Astellas Pharmaceuticals Company Profile
7.4.2 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
7.4.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.5 Amneal Pharms
7.5.1 Amneal Pharms Company Profile
7.5.2 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
7.5.3 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.6 Pharscin Pharma
7.6.1 Pharscin Pharma Company Profile
7.6.2 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
7.6.3 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
8 PRODUCTION AND SUPPLY FORECAST
8.1 Global Forecasted Production of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (2026-2031)
8.2 Global Forecasted Revenue of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (2026-2031)
8.3 Global Forecasted Price of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (2020-2031)
8.4 Global Forecasted Production of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Region (2026-2031)
8.4.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2026-2031)
8.4.2 East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2026-2031)
8.4.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2026-2031)
8.4.4 South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2026-2031)
8.4.5 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2026-2031)
8.4.6 Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2026-2031)
8.4.7 Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2026-2031)
8.4.8 Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2026-2031)
8.4.9 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2026-2031)
8.4.10 Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2026-2031)
8.5 Forecast by Type and by Application (2026-2031)
8.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2026-2031)
8.5.2 Global Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Application (2026-2031)
9 CONSUMPTION AND DEMAND FORECAST
9.1 North America Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
9.2 East Asia Market Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
9.3 Europe Market Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Countriy
9.4 South Asia Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
9.5 Southeast Asia Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
9.6 Middle East Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
9.7 Africa Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
9.8 Oceania Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
9.9 South America Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
9.10 Rest of the world Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
10 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
10.1 Marketing Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
11 MARKET DYNAMICS
11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis
12 CONCLUSION
13 APPENDIX
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Growth Rate by Type: 2026-2031
1.4.2 XIFAXAN
1.4.3 Viberzi
1.4.4 Lotronex
1.4.5 Other
1.5 Market by Application
1.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application: 2026-2031
1.5.2 Hospitals Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Other
1.6 Study Objectives
1.7 Overview of Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market
1.7.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Status and Outlook (2020-2031)
1.7.2 North America
1.7.3 East Asia
1.7.4 Europe
1.7.5 South Asia
1.7.6 Southeast Asia
1.7.7 Middle East
1.7.8 Africa
1.7.9 Oceania
1.7.10 South America
1.7.11 Rest of the World
2 MANUFACTURING COST STRUCTURE ANALYSIS
2.1 Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
2.2 Industry Chain Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity Market Share by Manufacturers (2020-2025)
3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Manufacturers (2020-2025)
3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Manufacturers (2020-2025)
4 IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS REGIONAL MARKET ANALYSIS
4.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Regions
4.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Regions (2020-2025)
4.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Regions
4.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Regions
4.3 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
4.3.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
4.3.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
4.3.3 Key Manufacturers in North America
4.3.4 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import and Export
4.4 East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
4.4.1 East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
4.4.2 East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
4.4.3 Key Manufacturers in East Asia
4.4.4 East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import & Export
4.5 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
4.5.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
4.5.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
4.5.3 Key Manufacturers in Europe
4.5.4 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import & Export
4.6 South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
4.6.1 South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
4.6.2 South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
4.6.3 Key Manufacturers in South Asia
4.6.4 South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import & Export
4.7 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
4.7.1 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
4.7.2 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
4.7.3 Key Manufacturers in Southeast Asia
4.7.4 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import & Export
4.8 Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
4.8.1 Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
4.8.2 Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
4.8.3 Key Manufacturers in Middle East
4.8.4 Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import & Export
4.9 Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
4.9.1 Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
4.9.2 Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
4.9.3 Key Manufacturers in Africa
4.9.4 Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import & Export
4.10 Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
4.10.1 Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
4.10.2 Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
4.10.3 Key Manufacturers in Oceania
4.10.4 Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import & Export
4.11 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
4.11.1 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
4.11.2 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
4.11.3 Key Manufacturers in South America
4.11.4 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import & Export
5 IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS SALES MARKET BY TYPE (2020-2031)
5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Historic Market Size by Type (2020-2025)
5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecasted Market Size by Type (2026-2031)
6 IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS CONSUMPTION MARKET BY APPLICATION(2020-2031)
6.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Historic Market Size by Application (2020-2025)
6.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecasted Market Size by Application (2026-2031)
7 COMPANY PROFILES AND KEY FIGURES IN IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS BUSINESS
7.1 Bausch Health
7.1.1 Bausch Health Company Profile
7.1.2 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
7.1.3 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.2 Allergan
7.2.1 Allergan Company Profile
7.2.2 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
7.2.3 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.3 Sebela Pharmaceuticals
7.3.1 Sebela Pharmaceuticals Company Profile
7.3.2 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
7.3.3 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.4 Astellas Pharmaceuticals
7.4.1 Astellas Pharmaceuticals Company Profile
7.4.2 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
7.4.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.5 Amneal Pharms
7.5.1 Amneal Pharms Company Profile
7.5.2 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
7.5.3 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.6 Pharscin Pharma
7.6.1 Pharscin Pharma Company Profile
7.6.2 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
7.6.3 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
8 PRODUCTION AND SUPPLY FORECAST
8.1 Global Forecasted Production of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (2026-2031)
8.2 Global Forecasted Revenue of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (2026-2031)
8.3 Global Forecasted Price of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (2020-2031)
8.4 Global Forecasted Production of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Region (2026-2031)
8.4.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2026-2031)
8.4.2 East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2026-2031)
8.4.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2026-2031)
8.4.4 South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2026-2031)
8.4.5 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2026-2031)
8.4.6 Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2026-2031)
8.4.7 Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2026-2031)
8.4.8 Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2026-2031)
8.4.9 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2026-2031)
8.4.10 Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue Forecast (2026-2031)
8.5 Forecast by Type and by Application (2026-2031)
8.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2026-2031)
8.5.2 Global Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Application (2026-2031)
9 CONSUMPTION AND DEMAND FORECAST
9.1 North America Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
9.2 East Asia Market Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
9.3 Europe Market Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Countriy
9.4 South Asia Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
9.5 Southeast Asia Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
9.6 Middle East Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
9.7 Africa Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
9.8 Oceania Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
9.9 South America Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
9.10 Rest of the world Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
10 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
10.1 Marketing Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
11 MARKET DYNAMICS
11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis
12 CONCLUSION
13 APPENDIX
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
LIST OF TABLES
Key Players Covered: Ranking by Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2020-2025
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Type: 2026-2031
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Application: 2026-2031
Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Rank and Commercial Production Date of Key Manufacturers
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Plants Distribution and Commercial Production Date
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity by Manufacturers
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Manufacturers (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share by Manufacturers (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Manufacturers (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers (2020-2025)
Global Market Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price of Key Manufacturers (2020-2025)
Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Sites and Area Served
Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Regions (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share by Regions (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Regions (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Regions (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Regions (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Regions (2020-2025)
Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Sales Volume in North America
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export
Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Sales Volume in East Asia
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export
Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Sales Volume in Europe
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export
Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Sales Volume in South Asia
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export
Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Sales Volume in Southeast Asia
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export
Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Sales Volume in Middle East
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export
Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Sales Volume in Africa
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export
Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Sales Volume in Oceania
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export
Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Sales Volume in South America
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Type (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Type (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecasted Market Size by Type (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Type (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Application (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Application (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecasted Market Size by Application (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Application (2026-2031)
Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Forecast by Region (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Forecast by Type (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Market Share Forecast by Type (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Revenue Forecast by Type (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Revenue Market Share Forecast by Type (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Forecast by Type (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Volume Forecast by Application (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value Forecast by Application (2026-2031)
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031 by Country
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031 by Country
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031 by Country
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031 by Country
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031 by Country
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031 by Country
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031 by Country
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031 by Country
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031 by Country
Rest of the world Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031 by Country
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2026-2031)
Key Challenges
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type: 2025 VS 2031
XIFAXAN Features
Viberzi Features
Lotronex Features
Other Features
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application: 2025 VS 2031
Hospitals Pharmacy Case Studies
Retail Pharmacy Case Studies
Other Case Studies
Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Report Years Considered
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Status and Outlook (2020-2031)
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2020-2031)
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2020-2031)
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2020-2031)
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2020-2031)
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2020-2031)
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2020-2031)
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2020-2031)
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2020-2031)
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2020-2031)
Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2020-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (2020-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity (2020-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (2020-2031)
Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in 2025
Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Industry Chain Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share by Regions in 2025
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Regions in 2025
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2020-2025
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2020-2025
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2020-2025
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2020-2025
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2020-2025
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2020-2025
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2020-2025
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2020-2025
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2020-2025
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2020-2025
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2020-2025
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2020-2025
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2020-2025
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2020-2025
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2020-2025
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2020-2025
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2020-2025
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2020-2025
Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity Growth Rate Forecast (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price and Trend Forecast (2020-2031)
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2026-2031)
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2026-2031)
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2026-2031)
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2026-2031)
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2026-2031)
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2026-2031)
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2026-2031)
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2026-2031)
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2026-2031)
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2026-2031)
Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031
Rest of the world Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031
Channels of Distribution
Porter's Five Forces Analysis
Key Executives Interviewed
Key Players Covered: Ranking by Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2020-2025
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Type: 2026-2031
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Application: 2026-2031
Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Rank and Commercial Production Date of Key Manufacturers
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Plants Distribution and Commercial Production Date
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity by Manufacturers
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Manufacturers (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share by Manufacturers (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Manufacturers (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers (2020-2025)
Global Market Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price of Key Manufacturers (2020-2025)
Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Sites and Area Served
Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Regions (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share by Regions (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Regions (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Regions (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Regions (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Regions (2020-2025)
Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Sales Volume in North America
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export
Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Sales Volume in East Asia
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export
Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Sales Volume in Europe
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export
Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Sales Volume in South Asia
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export
Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Sales Volume in Southeast Asia
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export
Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Sales Volume in Middle East
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export
Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Sales Volume in Africa
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export
Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Sales Volume in Oceania
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export
Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Sales Volume in South America
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Type (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Type (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecasted Market Size by Type (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Type (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Application (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Application (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecasted Market Size by Application (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Application (2026-2031)
Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Forecast by Region (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Forecast by Type (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Market Share Forecast by Type (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Revenue Forecast by Type (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Revenue Market Share Forecast by Type (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Forecast by Type (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Volume Forecast by Application (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value Forecast by Application (2026-2031)
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031 by Country
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031 by Country
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031 by Country
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031 by Country
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031 by Country
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031 by Country
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031 by Country
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031 by Country
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031 by Country
Rest of the world Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031 by Country
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2026-2031)
Key Challenges
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type: 2025 VS 2031
XIFAXAN Features
Viberzi Features
Lotronex Features
Other Features
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application: 2025 VS 2031
Hospitals Pharmacy Case Studies
Retail Pharmacy Case Studies
Other Case Studies
Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Report Years Considered
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Status and Outlook (2020-2031)
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2020-2031)
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2020-2031)
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2020-2031)
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2020-2031)
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2020-2031)
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2020-2031)
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2020-2031)
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2020-2031)
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2020-2031)
Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2020-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (2020-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity (2020-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (2020-2031)
Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in 2025
Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Industry Chain Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share by Regions in 2025
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Regions in 2025
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2020-2025
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2020-2025
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2020-2025
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2020-2025
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2020-2025
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2020-2025
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2020-2025
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2020-2025
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2020-2025
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2020-2025
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2020-2025
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2020-2025
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2020-2025
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2020-2025
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2020-2025
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2020-2025
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2020-2025
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2020-2025
Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Specification
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity Growth Rate Forecast (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price and Trend Forecast (2020-2031)
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2026-2031)
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2026-2031)
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2026-2031)
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2026-2031)
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2026-2031)
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2026-2031)
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2026-2031)
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2026-2031)
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2026-2031)
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast (2026-2031)
Rest of the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2026-2031)
North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031
East Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031
Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031
South Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031
Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031
Middle East Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031
Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031
Oceania Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031
South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031
Rest of the world Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast 2026-2031
Channels of Distribution
Porter's Five Forces Analysis
Key Executives Interviewed
